Jaguar LAA, Inc. Announces Acquisition of Assets Related to the Laminar Program

Jaguar LAA announced a transaction intended to advance its Laminar program for left atrial appendage closure in patients with non-valvular atrial fibrillation. The announcement supports development of Jaguar's differentiated medical-device approach, though financial terms, counterparties, and transaction magnitude were not disclosed in the provided article text.